Log in
Enquire now
‌

US Patent 10420727 Pharmaceutical antiretroviral composition

Patent 10420727 was granted and assigned to Cipla on September, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Cipla
Cipla
0
Current Assignee
Cipla
Cipla
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
104207270
Patent Inventor Names
Shrinivas Purandare0
Geena Malhotra0
Date of Patent
September 24, 2019
0
Patent Application Number
159726550
Date Filed
May 7, 2018
0
Patent Citations
‌
US Patent 10004721 Pharmaceutical antiretroviral composition
Patent Primary Examiner
‌
Jeffrey T. Palenik
0
Patent abstract

A pharmaceutical composition comprises at least one integrase inhibitor or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug and at least one antiretroviral or anti-HIV agent or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10420727 Pharmaceutical antiretroviral composition

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.